CRDF: Today’s Analyst Ratings and Price Target Adjustment

Feb 25, 2026
crdf:-today’s-analyst-ratings-and-price-target-adjustment

Key Takeaways

Piper Sandler maintains “Overweight” rating for Cardiff Oncology (CRDF) but lowers price target. New price target of USD 6.00 represents a

  • Latest
  • Popular

CONNECT & FOLLOW

SPECIAL POST

Elon Musk

Leave a comment